CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...

SAP reported a remarkable 28% year-on-year increase in cloud revenue, primarily driven by the Cloud ERP Suite, which itself grew by 34% in Q2. The current cloud backlog also saw a significant rise, ...

Stock prices in London closed higher on Friday, with markets maintaining the optimism that prevailed after US President ...

London stocks ended higher on Friday, supported by a positive shift in investor sentiment following US consumer confidence ...

London stocks had pared gains by midday on Friday, with GSK under the cosh. The FTSE 100 was flat at 8,971.33, having ...

The FTSE 100 index was up just 4.95 points at 8,977.59. The FTSE 250 gained 109.90 points, 0.5%, at 21,876.33, and the AIM All-Share climbed 2.54 points, 0.3%, at 771.47.

Reckitt Benckiser shares have lifted 2% or 110p to 5092p after the consumer goods giant secured a private equity buyer for ...

BofA cuts Bristol Myers' 2025 EPS and sales estimates slightly and flags medium-term pressure from generics, while ...

Traders have begun joking about what has become known as the “Taco” trade – an acronym of “Trump always chickens out” – each time the president makes an announcement.

GSK PLC GSK shares slid 1.10% to £13.95 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.46% to 8,718.75.

For new and old investors, taking full advantage of the stock market and investing ... likelihood its share price will decline as well. Thus, the more stocks you own with a #1 or #2 Rank and Scores of ...

Value investors should also note GSK's Price/Sales ratio of 1.9X. A company's earnings performance is important for value investors as well. For fiscal 2025, five analysts revised their earnings ...